Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies

Multiple Sclerosis

Volumn 3, Issue 2, 1997, Pages 93-97

  Comi, G ^a   Nemni, R ^a   Amadio, S ^a   Galardi, G ^a   Leocani, L ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; Immunoglobulin; Intravenous gamma globulin; Monoclonal gammopathy; Multifocal motor neuropathy; Plasma exchange; Steroid treatment; Treatment

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; STEROID;

CHRONIC INFLAMMATION; CLINICAL TRIAL; CONFERENCE PAPER; DEMYELINATING NEUROPATHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; IMMUNE MEDIATED INJURY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MONOCLONAL IMMUNOGLOBULINEMIA; MOTOR NEUROPATHY; PLASMAPHERESIS; POLYNEUROPATHY; STEROID THERAPY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0030769655     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859700300207     Document Type: Conference Paper

References (53)

1. Fanaroff AA, Korones SB, Wright LL, et al. (1994) A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 330: 1007-1013.
2. Schwarzt SA. (1993) Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes. Clin Rev Allergy 10: 1-12.
3. Ronda N, Hurez V, Kazatchine MD. (1993) Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases. Vox Sang 65: 65-72.
4. Sullivan KM, Kopecky KJ, Jocom J, et al. (1990) Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 323: 705-712.
5. Kaji R, Shibasaki H, Kimura J. (1992) Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology 42: 506-509.
6. Corse AM, et al. (1996) Sensory nerve pathology in multifocal motor neuropathy. Ann Neurol 39: 319-325.
7. Feldman EL, Bromberg MB, Alberts JW, Pestronk A. (1991) Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 30: 397-401.
8. Krarup C, et al. (1990) A syndrome of asymmetric limb weakness with motor conduction block. Neurology 40: 118-127.
9. Parry GJ, Clarke S. (1988) Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 11: 103-107.
10. Pestronk A, Cornblath DR, Ilyas AA, et al. (1988) A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 24: 73-78.
11. Bouche P, Moulonguet A, Younes-Chennoufi AB, et al. (1995) multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 59: 38-44.
12. Chaudry V, Corse AM, Cornblath DR, et al. (1993) Multifocal motor neuropathy: response to human immune globulin. Ann Neurol 33: 237-242.
13. Comi G, et al. (1944) Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 57 (suppl): 35-37.
14. Nobile-Orazio E, et al. (1993) High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 43: 537-544.
15. Parry GJ. (1996) AAEM case report # 30: multifocal motor neuropathy. Muscle Nerve 19: 269-276.
16. Azulay JP, Blin O, Pouget J, et al. (1994) Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study. Neurology 44: 429-432.
17. Van Den Berg LH, Kerkoff H, Oey PL, et al. (1995) Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 59: 248-452.
18. Austin JH. (1958) Recurrent polyneuropathies and their corticosteroid treatment. With five-year observation of a placebo-controlled case treated with corticotropin, cortisone, and prednisone. Brain 81: 157-192.
19. Dyck PJ, et al. (1982) Prednisone improves chronic inflammatory domyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 11: 136-141.
20. Hodkinson SJ, Pollard JD, McLeod JG. (1990) Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 53: 327-330.
21. Jongen PJH, Joosten EMG, Berden JHM, Gabre LS-Festen AAWM. (1988) Cyclosporine therapy in chronic inflammatory demyelinating polyradiculoneuropathy - a preliminary report of clinical results in two patients. Transplant Proc 20 (suppl 4): 329-332.
22. McCombe PA, Pollard JD, McLeod JG. (1987) Chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and electrophysiological study of 92 cases. Brain 110: 1617-1630.
23. Pentland B, Adams GGW, Mawdsley C. (1982) Chronic idiopathic polyneuropathy treated with azathioprine. J Neurol Neurosurg Psychiatry 45: 866-869.
24. Dyck PJ, et al. (1985) Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy. Neurology 35: 1173-1176.
25. Dyck PJ, Daube J, O'Brien P, et al. (1986) Plasma exchange in chronic inflammatory demyelinating polyneuropathy. N Engl J Med 314: 461-465.
26. Cornblath Dr, Chaudry V, Griffin JW. (1991) Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin Ann Neurol 30: 104-106.
27. Faed JM, et al. (1989) High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polynouropathy. Neurology 39: 422-425.
28. Hoang-Xuan K, Léger JM, Ben Younes-Chennoufi, et al. (1993) Traitement des neuropathies dysimmunitaires par immunoglobulines polyvalentes intraveineuses. Rev Neurol 149: 385-392.
29. Nemni R, et al. (1994) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments. J Neurol Neurosurg Psychiatry 57 (suppl): 43-45.
30. Van Doorn PA, et al. (1991) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement. Arch Neurol 48: 217-220.
31. Vermeulen M, et al. (1993) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 56: 36-39.
32. Dyck PJ, Litchy WJ, Kratz KM, et al. (1994) A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36: 838-845.
33. Gorson KC, Allam G, Ropper AH. (1997) Chronic inflammatory demyelinating polyneuropathy: Clinical feature and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 48: 321-328.
34. Kahn SN, Riches PG, Kohn J. (1980) Paraproteinemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins. J Clin Pathol 33: 617-621.
35. Kelly JJ, Kyle RA, O'Brien PC, Dyck PJ. (1981) Prevalence of monoclonal protein in peripheral neuropathy. Neurology 31: 1480-1483.
36. Vrethem M, et al. (1993) Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies. J Neurol Sci 114: 193-199.
37. Nobile-Orazio E, Manfredini E, Carpo M, et al. (1994) Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 36: 416-424.
38. Dalakas MC, Engel WK. (1981) Polyneuropathy with monoclonal gammopathy: studies of 11 patients. Ann Neurol 10: 45-52.
39. Kelly JJ, Adelamn E, Berkman E, Bhan I. (1988) Polyneuropathies associated with IgM monoclonal gammopathies. Arch Neurol 45: 1355-1359.
40. Yeung KB, Thomas PK, King RHM, et al. (1991) The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol 238: 383-391.
41. Nobile-Orazio E, Baldini L, Barbieri S, et al. (1988) Treatment of patients with neuropathy and anti-MAG IgM M-proteins. Ann Neurol 24: 93-97.
42. Waterston JA, Brown MM, Ingram DA, Swash M. (1992) Cyclosporin A therapy in paraprotein-associated neuropathy. Muscle Nerve 15: 445-448.
43. Dellagi K, Chedru F, Clauvel JP, Brouet JC. (1984) Neuropathie periphérique de la macroglobulinemie de Waldenstrom. Presse Med 13: 1199-1201.
44. Sherman WH, et al. (1984) Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia. J Neurol Neurosurg Psychiatry 47: 813-819.
45. Simmons Z, Bromberg MB, Feldman EL, Blaivas M. (1993) Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance. Muscle Nerve 16: 77-83.
46. Dyck PJ, Low PA, Windebank AJ, et al. (1991) Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 325: 1482-1486.
47. Ellie E, et al. (1996) Neuropathy associated with benign anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological, pathological findings and response to treatment in 33 cases. J Neurol 243: 34-43.
48. Oksenehendler E, Chevret S, Léger JM, et al. (1995) Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. J Neurol Neurosurg Psychiatry 59: 243-247.
49. Cook D, et al. (1990) High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy. Neurology 40: 212-214.
50. Léger JM, Younes-Chennoufi AB, Chassande B, et al. (1994) Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry 57 (suppl): 46-49.
51. Kaji R, Hirota N, Oka N, et al. (1994) Anti-GM1 antibodies and impaired blood-nerve barrier may interfere with remyelination in multifocal motor neuropathy. Muscle Nerve 17: 108-110.
52. Van Doorn PA, et al. (1990) High dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double blind placebo controlled cross over study. Neurology 40: 209-212.
53. Vermeulen M, et al. (1985) Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy. J Neurol Sci 70: 317-326.